Samsung Biologics has entered into a strategic partnership with GeneQuantum Healthcare, a China biotech company, to jointly develop an antibody drug conjugate (ADC) for the treatment of non-small-cell lung carcinoma (NSCLC), triple-negative breast cancer (TNBC), and other solid tumors. The agreement
Genome & Co., a global pioneer in microbiome therapeutics, has initiated clinical trials of GEN-001, an anti-cancer microbiome therapeutic (NCT04601402), in the United States.GEN-001 is an oral microbiome therapeutic candidate, and in this clinical trial, it will be administered to American patients
Samsung Biologics has opened its first U.S. CDO R&D Center in San Francisco, bringing its contract development services closer to global clients.“We’re starting the CDO R&D Center today in San Francisco, and we plan to continue our expansion into Boston, Europe, and China moving forward. In 2020 and
South Korean Minister of Trade, Industry and Energy Sung Yun-mo and U.K. Secretary of State for Business, Energy and Industrial Strategy Alok Sharma discussed bilateral economic cooperation on Oct. 26.The United Kingdom is South Korea’s second-largest export destination in Europe behind Germany. Sou
The author is an analyst of KB Securities. She can be reached at kahye.hong@kbfg.com. -- Ed. Initiate coverage with POSITIVE rating; top pick: Samsung BiologicsWe initiate coverage of Pharmaceutical & Biotechnology with a POSITIVE rating. Our optimism lies in our view that the growing global biophar
The author is an analyst of NH Investment & Securities. They can be reached at jaemin.ahn@nhqv.com. -- Ed. Interest in telcos as value stocks remains low, despite the fact that they have entered an earnings growth phase in 2020 thanks to eased 5G competition and reduced capex. That said, positive ev
Global semiconductor companies are increasing their investments in M&A and R&D in order to get the upper hand in the AI chip market, which is expected to grow from US$18.4 billion to US$117.9 billion for 10 years to come.According to market research firm IC Insights, this year’s M&A volume in the gl
Incheon Free Economic Zone (IFEZ) Authority announced on Oct. 21 that Commissioner Lee Won-jae visited SCM Lifescience, a company in Songdo International City, on Oct. 20 to explore ways to support biotech venture companies in the Songdo Bio Cluster.Lee took a tour of research and manufacturing faci
Samsung Biologics has entered into a partnership agreement with biotech Dinona, further expanding its CDO capabilities to provide a full scope of its development services from cell line development, process development, to non-clinical and clinical material manufacturing.Under this agreement, Samsun
The author is an analyst of KB Securities. She can be reached at sukyung.lee@kbfg.com. -- Ed.Company Overview: A comprehensive pharmaceutical/bio company In 2013, the company, which was established in 1941, was spun off, resulting in the creation of two entities: holding company CKD Holdings and ope
Samsung Biologics has entered into a partnership agreement with BioEleven to develop and manufacture BN-101A, a third-generation immunotherapy to treat cancer. Under this agreement, Samsung Biologics will provide a full scope of its development services from cell line development, process developmen
South Korea has ushered in a new era of Wi-Fi as the government has allocated a new frequency band for next-generation Wi-Fi, which will be five times faster than the current service.The Korean Ministry of Science and ICT announced on Oct. 15 that it will supply the 6 GHz frequency band for unlicens
Hyundai Motor Group is preparing a corporate governance reform as its complex governance structure needs to be better organized for its new chairman Chung Eui-sun’s stable control and succession. At present, the chairman owns 2.62 percent of Hyundai Motor Co., 1.74 percent of Kia Motors, 23.29 perce
The Korea Industry Alliance Forum recently simulated separate audit committee member appointment based on the so-called 3 percent rule in relation to 15 major companies and announced on Oct. 13 that a person recommended by a foreign hedge fund is likely to be appointed in 13 out of the 15.The 3 perc
Lawmaker Shin Jeong-hoon remarked on Oct. 13 that Korea Trade Insurance Corp.’s overseas receivables totaled 4,745 billion won at the end of July, including 1,389.2 billion won that is uncollectible.The United States accounted for 34.2 percent of the uncollectible portion, followed by Poland (12.5 p
Hyundai Motor Group held a virtual groundbreaking ceremony for the construction of an innovation center in Singapore on Oct. 13. The Hyundai Motor Group Innovation Center in Singapore (HMGICS) will act as an open innovation lab for the group’s future mobility research and development. “HMGICS is a m
The author is an analyst of NH Investment & Securities. He can be reached at william.ku@nhqv.com. -- Ed. With Sanofi confirming its decision to return the rights for Efeglenatide, we expect Hanmi to book unpaid R&D expenses in its accounting, leading to a large-scale operating loss in 3Q20. We maint
The South Korean government released an AI semiconductor industry development strategy on Oct. 12. The idea is to achieve a global market share of 20 percent and have 20 innovative companies and 3,000 top-level engineers in the industry by 2030.AI semiconductors, which are characterized by high perf
Selling fresh produce from an island to the whole nationIn 1995, when then-33-year-old Kim Jeong-yeol started his fruit and vegetable farm on Korea’s Jeju Island, he had a lot to learn. Jeju was his home, so he knew his way around. But his parents had run a factory and he was completely new to farmi
COVID-19 is a challenge that demands companies and governments address multiple dimensions that go beyond the pandemic's health implications. The Korean government, says Lee Kang-shin, chairman of the Incheon Chamber of Commerce & Industry, needs to come up with policies to help companies naviga